INSIGHTS ON DRUG DEVELOPMENT
-
![Overcoming Challenges In Ophthalmic Formulations With Right Quality Of Excipients]( "Overcoming Challenges In Ophthalmic Formulations")
Overcoming Challenges In Ophthalmic FormulationsDiscover key strategies for overcoming formulation challenges in ophthalmic drug development and learn how selecting the right excipients supports quality, compliance, and safety.
-
![Pill capsule in doctors hand-GettyImages-922565512]( "API In Capsule Vs. The Lost Art Of Formulation Development")
API In Capsule Vs. The Lost Art Of Formulation DevelopmentAPI-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
![Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders Alzheimer's Disease]( "Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's Disease")
Role Of Chronic Inflammation In Risk For Neurodegenerative Disorders: Alzheimer's DiseaseExplore how genetic and environmental risk factors interact to heighten Alzheimer's disease risk, and gain insight into a novel therapeutic approach.
-
![samsung adc webinar thumb]( "Introducing 2 New Highly Effective ADC Payloads For Cancer Therapeutics")
Introducing 2 New Highly Effective ADC Payloads For Cancer TherapeuticsUnlock the potential of antibody-drug conjugates (ADCs) by exploring our novel payloads, designed for easy access and evaluation, to accelerate your ADC drug development with proven efficacy and safety.
-
Concept To Market: Scaling And Manufacturing Semi-Solid Topical Drugs2/23/2026
Learn how formulation, processing, and scale‑up choices impact the stability, structure, and performance of semi‑solid topicals while ensuring consistent quality through development.
-
Identification Of GLP-1 Analog Oligomeric States Using SEC-MALS7/29/2025
Discover how SEC-MALS enables precise characterization of GLP-1a therapeutics to ensure formulation integrity and enhance safety, efficacy, and regulatory confidence.
-
Small Molecule Orphan Drugs: Status Quo, Challenges, And Perspectives3/11/2026
By establishing robust manufacturing processes and scalable production strategies from the outset, developers can help de-risk orphan drug production, improve efficiency, and position their programs for greater long-term success.
-
Assessing Developability And Designing Advanceable Formulations From The Start1/15/2026
Discover how early developability assessments and a quality-by-design approach can streamline formulation, reduce risk, and accelerate your path to successful, cost-effective drug development.
-
Calcium Carbonate As TiO2 Alternative In Coating11/7/2025
Explore how calcium carbonate can replace titanium dioxide in tablet coating, as well as learn formulation strategies and review color performance data to support high-quality finishes in applications.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1218520471-development-research-lab-PPE]( "Early Development: Accelerating Molecules Through To Proof-Of-Concept")
Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.
-
![Elizabeth Hata Pharmaceutical 10 Station Tablet Press]( "Used Elizabeth Hata Pharmaceutical 10 Station Tablet Press")
Used Elizabeth Hata R&D tablet press, model EP200, B/D tooled with 10 station turret, 5 stations each B and D, 16 mm B, 22 mm D max tablet diameter, 17 mm B, 18 mm D max depth of fill, rated up to 6000 tablets/hour, with feed hoppers and feed frames, Machine #81, built 2011.
-
![MabSelect VL Affinity Resin]( "Resin Offering High Productivity And Robust Processes")
MabSelect™ VL affinity resin uses a protein L ligand with strong affinity for the variable region of a human antibody’s kappa light chain. The resin offers high productivity and robust processes for affinity capture of bispecific antibodies and antibody fragments containing the kappa light chain and offers a good capture alternative for antibody variants that does not bind to protein A.
-
![M165 C]( "Encoded Stereo Microscopes - Reproduce Images In Minutes")
Encoded stereo microscopes Leica M165 C - Total recall of your settings
Your goal: high-quality images that allow measurements and can be accurately repeated with minimal effort. The Leica coded stereo microscopes help you to pave the way to correct results.
-
Coded microscopes consistently deliver calibrated and comparable images
-
Reproduce images in moments with the Leica “Store and Recall” function
-
Fully apochromatic corrected zoom optics deliver high quality images
-
Customize the microscope system to your task with the exclusive range of accessories
-
-
![iStock-474771466-inhaler-inhale]( "Inhaled Product Development")
Our integrated capabilities and vast knowledge encompasses pre-formulation sciences, formulation development, device evaluation, clinical trial manufacturing and the clinical assessment of a variety of inhaled formats for nasal and pulmonary delivery.
